The increased risk of NAFLD was also observed at the highest RCAN2 levels after adjusting for age and sex in Model 2, and after further controlling BMI, WC, BP, FBG in Model 3, as well as adjusting for WBC, NEU, ALT, AST, GGT, ALP, UA, and eGFR in Model 4, and even adjusting for TC, TG, HDL-C, and LDL-C in Model 5. The gene discussed is RCAN2; the disease is metabolic dysfunction-associated steatotic liver disease.